Skip to main content
Log in

Radioreceptor assay for determination of the antimuscarinic drug ipratropium bromide in man

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

A radioreceptor assay for the determination of ipratropium bromide in human plasma has been developed, using [3H] N-methyl-scopolamine as a radioligand to label muscarinic cholinergic receptors in a membrane preparation of rat cerebral cortex. there was no interference due to the cross-reactivity of 3 metabolites of ipratropium with the parent compound (5.2, 1.5 and 0.004%, respectively). The validity of the assay was checked between 20 pg/ml and 1000 pg/ml drug.

In a pilot study plasma levels following a single oral dose of 30 mg were determined to examine the applicability of the radioreceptor assay to clinical and pharmacokinetic studies, and for measurement of plasma levels after therapeutic oral doses. The peak plasma concentration in three healthy volunteers (\(\bar \times \)=322 pg/ml) occurred within 1–3 h.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Brisse B, Bender F (1982) Autonome Innervation des Herzens. Steinkopff, Darmstadt

    Google Scholar 

  2. Gross NJ, Skorodin MS (1984) Anticholinergic, antimuscarinic bronchodilators. Am Rev Respir Dis 129: 856–870

    Google Scholar 

  3. Bauer R, Kuhn F-J, Stockhaus K, Wick H (1976) Allgemeine Pharmakologie und sekretionshemmende Wirkung von (8r)-3α-Hydroxy-8-isopropyl-1αH, 5αH-tropaniumbromid-(±)-tropat (Ipratropiumbromid). Drug Res 26: 974–980

    Google Scholar 

  4. Bauer R, Püschmann S, Wick H (1976) Wirkung von (8r)-3α-Hydroxy-8-isopropyl-1αH, 5αH-tropaniumbromid-(±)-tropat (Ipratropiumbromid) auf Spasmen des Tracheobronchialbaumes und die Bronchialsekretion, die Speichelsekretion, EKG und Herzfrequenz. Drug Res 26: 981–985

    Google Scholar 

  5. Adlung J, Höhle KD, Zeren S, Wahl D (1976) Untersuchungen zur Pharmakokinetik und Biotransformation von Ipratropiumbromid am Menschen. Drug Res 26: 1005–1010

    Google Scholar 

  6. Förster H-J, Kramer I, Pook K-H, Wahl D (1976) Untersuchungen zur Pharmakokinetik und Biotransformation von Ipratropiumbromid bei Ratte und Hund. Drug Res 26: 992–1005

    Google Scholar 

  7. Ensing K, Kluivingh F, Gerding TK, de Zeeuw RA (1984) Development of a sensitive radioreceptor assay for oxyphenonium in plasma and urine. J Pharm Pharmacol 36: 235–239

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ensinger, H.A., Wahl, D. & Brantl, V. Radioreceptor assay for determination of the antimuscarinic drug ipratropium bromide in man. Eur J Clin Pharmacol 33, 459–462 (1987). https://doi.org/10.1007/BF00544235

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00544235

Key words

Navigation